Contraception
Volume 82, Issue 1 , Pages 17-37 , July 2010

Progestogen-only contraceptive use among breastfeeding women: a systematic review

  • Nathalie Kapp

      Affiliations

    • Department of Reproductive Health and Research, World Health Organization, CH-1211, Geneva 27, Switzerland
    • Corresponding Author InformationCorresponding author. Department of Reproductive Health and Research, World Health Organization, 20 Avenue Appia, CH-1211 Geneva 27, Switzerland.
    • ,
  • Kathryn Curtis

      Affiliations

    • Centers for Disease Control and Prevention, Atlanta, GA, 3034127, USA
    • ,
  • Kavita Nanda

      Affiliations

    • Family Health International, Research Triangle Park, NC 27709, USA

Received 1 February 2010 ,Accepted 2 February 2010.

References 

  1. Halderman LD, Nelson AL. Impact of early postpartum administration of progestin-only hormonal contraceptives compared with nonhormonal contraceptives on short-term breast-feeding patterns. Am J Obstet Gynecol. 2002;186:1250–1256
  2. Gray RH, Campbell OM, Apelo R, et al. Risk of ovulation during lactation. Lancet. 1990;335:25–29
  3. Labbok MH, Hight-Laukaran V, Peterson AE, Fletcher V, von HH, Van Look PF. Multicenter study of the lactational amenorrhea method (LAM): I. Efficacy, duration, and implications for clinical application. Contraception. 1997;55:327–336
  4. Gartner LM, Morton J, Lawrence RA, et al. Breastfeeding and the use of human milk. Pediatrics. 2005;115:496–506
  5. Horta B, Bahl R, Martines J, Victora C. Evidence of the long-term effects of breastfeeding: systematic reviews and meta-analysis. Geneva, Switzerland: World Health Organization; 2007;
  6. Britton C, McCormick FM, Renfrew MJ, Wade A, King SE. Support for breastfeeding mothers. Cochrane Database Syst Rev. 2007;(1):CD001141
  7. World Health Organization . Global strategy for infant and young child feeding. Geneva, Switzerland: World Health Organization; 2003;
  8. Diaz S. Contraceptive implants and lactation. Contraception. 2002;65:39–46
  9. Schwallie PC. The effect of depot-medroxyprogesterone acetate on the fetus and nursing infant: a review. Contraception. 1981;23:375–386
  10. Croxatto HB, Diaz S, Peralta O, et al. Fertility regulation in nursing women .4. Long-term influence of a low-dose combined oral-contraceptive initiated at day 30 postpartum upon lactation and infant growth. Contraception. 1983;27:13–25
  11. Harris RP, Helfand M, Woolf SH, et al. Current methods of the US Preventive Services Task Force: a review of the process. Am J Preven Med. 2001;20(Suppl):21–35
  12. Mohllajee AP, Curtis KM, Flanagan RG, Rinehart W, Gaffield ML, Peterson HB. Keeping up with evidence: a new system for WHO's evidence-based family planning guidance. Am J Preven Med. 2005;28:483–490
  13. Kamal I, Hefnawi F, Ghoneim M, Abdallah M, Abdel RS. Clinical, biochemical, and experimental studies on lactation. V. Clinical effects of steroids on the initiation of lactation. Am J Obstet Gynecol. 1970;108:655–658
  14. Karim M, Ammar R, El-mahgoub S, El-ganzoury B, Fikri F, Abdou I. Injected progestogen and lactation. Br Med J. 1971;1:200–203
  15. Guiloff E, Ibarrapo A, Zanartu J, Toscanin C, Mischler TW, Gomezrog C. Effect of contraception on lactation. Am J Obstet Gynecol. 1974;118:42–45
  16. Giner VJ, Cortes G, Sotelo LA, Bondani G. Effect of daily oral administration of 0.350 mg of norethindrone on lactation and on the composition of milk. Ginecol Obstet Mex. 1976;40:31–39
  17. Zanartu J, Aguilera E, Munoz-Pinto G. Maintenance of lactation by means of continuous low-dose progestogen given post-partum as a contraceptive. Contraception. 1976;13:313–318
  18. Seth U, Yadava HS, Agarwal N, Laumas KR, Hingorani V. Effect of a subdermal silastic implant containing norethindrone acetate on human lactation. Contraception. 1977;16:383–398
  19. Croxatto HB, Diaz S, Peralta O, et al. Fertility regulation in nursing women. II Comparative performance of progesterone implants versus placebo and copper T. Am J Obstet Gynecol. 1982;144:201–208
  20. Heikkila M, Luukkainen T. Duration of breast-feeding and development of children after insertion of a levonorgestrel-releasing intrauterine contraceptive device. Contraception. 1982;25:279–292
  21. Diaz S, Peralta O, Juez G, et al. Fertility regulation in nursing women. VI. Contraceptive effectiveness of a subdermal progesterone implant. Contraception. 1984;30:311–325
  22. Jimenez J, Ochoa M, Soler MP, Portales P. Long-term follow-up of children breast-fed by mothers receiving depot-medroxyprogesterone acetate. Contraception. 1984;30:523–533
  23. WHO Special Programme of Research Development and Research Training in Human Reproduction. Effects of hormonal contraceptives on milk volume and infant growth. Contraception. 1984;30:505–522
  24. Abdulla KA, Elwan SI, Salem HS, Shaaban MM. Effect of early postpartum use of the contraceptive implants, NORPLANT, on the serum levels of immunoglobulins of the mothers and their breastfed infants. Contraception. 1985;32:261–266
  25. Shaaban MM, Salem HT, Abdullah KA. Influence of levonorgestrel contraceptive implants, NORPLANT, initiated early postpartum upon lactation and infant growth. Contraception. 1985;32:623–635
  26. Shikary ZK, Betrabet SS, Toddywala WS, Patel DM, Datey S, Saxena BN. Pharmacodynamic effects of levonorgestrel (LNG) administered either orally or subdermally to early postpartum lactating mothers on the urinary levels of follicle stimulating hormone (FSH), luteinizing hormone (LH) and testosterone (T) in their breast-fed male infants. Contraception. 1986;34:403–412
  27. Zacharias S, Aguilera E, Assenzo JR, Zanartu J. Effects of hormonal and nonhormonal contraceptives on lactation and incidence of pregnancy. Contraception. 1986;203–213
  28. Affandi B, Karmadibrata S, Prihartono J, Lubis F, Samil RS. Effect of Norplant on mothers and infants in the postpartum period. Adv Contracept. 1986;2:371–380
  29. McCann MF, Moggia AV, Higgins JE, Potts M, Becker C. The effects of a progestin-only oral contraceptive (levonorgestrel 0.03 mg) on breast-feeding. Contraception. 1989;40:635–648
  30. Shaaban MM. Contraception with progestogens and progesterone during lactation. J Steroid Biochem Mol Biol. 1991;40(4-6):705–710
  31. World Health Organization, Task Force for Epidemiological Research on Reproductive Health; Special Programme of Research, Development, and Research Training in Human Reproduction . Progestogen-only contraceptives during lactation: II. Infant development. Contraception. 1994;50:55–68
  32. World Health Organization Task force for Epidemiological Research on Reproductive Health; Special Programme of Research, Development and Research Training in Human Reproduction. Progestogen-only contraceptives during lactation: I. Infant growth.. Contraception. 1994;50:35–53
  33. Abdel-Aleem H, bol-Oyoun E, Shaaban MM, el-Saeed M, Shoukry M, Makhlouf A, et al. The use of nomegestrol acetate subdermal contraceptive implant, uniplant, during lactation. Contraception. 1996;54:281–286
  34. Sivin I, Diaz S, Croxatto HB, et al. Contraceptives for lactating women: a comparative trial of a progesterone-releasing vaginal ring and the copper T 380A IUD. Contraception. 1997;55:225–232
  35. Hannon PR, Duggan AK, Serwint JR, Vogelhut JW, Witter F, DeAngelis C. The influence of medroxyprogesterone on the duration of breast-feeding in mothers in an urban community. Arch Pediatr Adolesc Med. 1997;15:490–496
  36. Diaz S, Zepeda A, Maturana X, Reyes MV, Miranda P, Casado ME, et al. Fertility regulation in nursing women : IX. Contraceptive performance, duration of lactation, infant growth, and bleeding patterns during use of progesterone vaginal rings, progestin-only pills, Norplant(R) implants, and Copper T 380-A intrauterine devices. Contraception. 1997;56:223–232
  37. Lawrie TA, Hofmeyr GJ, De Jager M, Berk M, Paiker J, Viljoen E. A double-blind randomised placebo controlled trial of postnatal norethisterone enanthate: the effect on postnatal depression and serum hormones. Brit J Obstet Gynaecol. 1998;105:1082–1090
  38. Massai R, Miranda P, Valdes P, Lavin P, Zepeda A, Casado ME, et al. Preregistration study on the safety and contraceptive efficacy of a progesterone-releasing vaginal ring in Chilean nursing women. Contraception. 1999;60:9–14
  39. Coutinho EM, Athayde C, Dantas C, Hirsch C, Barbosa I. Use of a single implant of elcometrine (ST-1435), a nonorally active progestin, as a long acting contraceptive for postpartum nursing women. Contraception. 1999;59:115–122
  40. Bjarnadottir RI, Gottfredsdottir H, Sigurdardottir K, Geirsson RT, Dieben TO. Comparative study of the effects of a progestogen-only pill containing desogestrel and an intrauterine contraceptive device in lactating women. BJOG. 2001;108:1174–1180
  41. Baheiraei A, Ardsetani N, Ghazizadeh S. Effects of progestogen-only contraceptives on breast-feeding and infant growth. Int J Gynaecol Obstet. 2001;74:203–205
  42. Massai MR, Diaz S, Quinteros E, Reyes MV, Herreros C, Zepeda A, et al. Contraceptive efficacy and clinical performance of Nestorone implants in postpartum women. Contraception. 2001;64:369–376
  43. Schiappacasse V, Diaz S, Zepeda A, Alvarado R, Herreros C. Health and growth of infants breastfed by Norplant contraceptive implants users: a six-year follow-up study. Contraception. 2002;66:57–65
  44. Diaz S, Herreros C, Juez G, et al. Fertility regulation in nursing women: VII. Influence of NORPLANT levonorgestrel implants upon lactation and infant growth. Contraception. 1985;32:53–74
  45. Shaamash AH, Sayed GH, Hussien MM, Shaaban MM. A comparative study of the levonorgestrel-releasing intrauterine system Mirena(R) versus the Copper T380A intrauterine device during lactation: breast-feeding performance, infant growth and infant development. Contraception. 2005;72:346–351
  46. Taneepanichskul S, Reinprayoon D, Thaithumyanon P, Praisuwanna P, Tosukhowong P, Dieben T. Effects of the etonogestrel-releasing implant Implanon and a nonmedicated intrauterine device on the growth of breast-fed infants. Contraception. 2006;73:368–371
  47. Reinprayoon D, Taneepanichskul S, Bunyavejchevin S, et al. Effects of the etonogestrel-releasing contraceptive implant (Implanon(R)) on parameters of breastfeeding compared to those of an intrauterine device. Contraception. 2000;62:239–246
  48. Brito MB, Ferriani RA, Quintana SM, Yazlle MEHD, de Sa MFS, Vieira CS. Safety of the etonogestrel-releasing implant during the immediate postpartum period: a pilot study. Contraception. 2009;80(6):519–526
  49. Truitt ST, Fraser AB, Grimes DA, Gallo MF, Schulz KF. Hormonal contraception during lactation: systematic review of randomized controlled trials. Contraception. 2003;68:233–238
  50. Narducci U, Piatti N. Use of Depo Provera as a contraceptive in the puerperium. Minerva Ginecol. 1973;25:107–111
  51. Melis GB, Strigini F, Fruzzetti F, et al. Norethisterone enanthate as an injectable contraceptive in puerperal and non-puerperal women. Contraception. 1981;23:77–88
  52. Moggia AV, Harris GS, Dunson TR, Diaz R, Moggia MS, Ferrer MA, et al. A comparative study of a progestin-only oral contraceptive versus non-hormonal methods in lactating women in Buenos Aires, Argentina. Contraception. 1991;44:31–43
  53. McEwan JA, Joyce DN, Tothill AU, Hawkins DF. Early experience in contraception with a new progestogen. Contraception. 1977;16:339–350
  54. West CP. The acceptability of a progestagen-only contraceptive during breast-feeding. Contraception. 1983;27:563–569
  55. Massai R, Quinteros E, Reyes MV, et al. Extended use of a progesterone-releasing vaginal ring in nursing women: a Phase II clinical trial. Contraception. 2005;72:352–357
  56. Thulier D, Mercer J. Variables associated with breastfeeding duration. J Obstet Gynecol Neonatal Nurs. 2009;38(3):259–268
  57. Nilsson S, Nygren KG, Johansson ED. d-Norgestrel concentrations in maternal plasma, milk, and child plasma during administration of oral contraceptives to nursing women. Am J Obstet Gynecol. 1977;129:178–184
  58. Saxena BN, Shrimanker K, Grudzinskas JG. Levels of contraceptive steroids in breast milk and plasma of lactating women. Contraception. 1977;16(6):605–613
  59. Betrabet SS, Shikary ZK, Toddywalla VS, Toddywalla SP, Patel D, Saxena BN. ICMR Task Force Study on Hormonal Contraception. Transfer of norethisterone (NET) and levonorgestrel (LNG) from a single tablet into the infant's circulation through the mother's milk. Contraception. 1987;35(6):517–522
  60. Shikary ZK, Betrabet SS, Patel ZM, et al. ICMR Task Force Study on Hormonal Contraception. Transfer of levonorgestrel (LNG) administered through different drug delivery systems from the maternal circulation into the newborn infant's circulation via breast milk. Contraception. 1987;35:477–486

☆ The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the World Health Organization or Centers for Disease Control and Prevention.

PII: S0010-7824(10)00046-6

doi: 10.1016/j.contraception.2010.02.002

Contraception
Volume 82, Issue 1 , Pages 17-37 , July 2010

Article Tools